Dr. Johanna Olson-Kennedy, one of the nation’s leading advocates for “gender-affirming care” for kids, refuses to release a ten-million-dollar taxpayer-funded study because the results don’t support continued trans-medical intervention. However, full disclosure is necessary for the trans community to make important life decisions.
The nine-year study, bought and paid for by hardworking Americans, essentially revealed that after receiving puberty-blockers, these young children did not improve in the area of mental health. This is important information because these children most certainly were diagnosed with some mental illness prior to being seen for gender dysphoria (the belief that one’s body is the wrong sex), another psychiatric diagnosis.
Dr. Olson-Kennedy has refused to release the study because she believes that it could be “weaponized” and used as proof that “we shouldn’t use blockers.” The puberty-blocker “treatments” supposedly delay physical development, so the body feels more like the gender identified with.
What the Olson-Kennedy study revealed was that despite being on puberty-blockers, the kids were no better off with their mental health. In a nutshell, kids thought they’d be happy if they could be the sex they identified with, but in fact, this was not reflected in the study. After two years, despite the treatment, there was no significant improvement in the kids’ mental health.
For those of us who follow psychiatric drugging, it is of interest that the research data are being withheld because too often these studies fail to consider the psychiatric drugging that occurred prior to the request for “transition” “treatment.” In other words, how many of these kids were on psychiatric mind-altering drugs prior to feeling the need to transition? What psychiatric diagnoses were involved, and what drugs were prescribed prior to the child’s belief that becoming another sex would be more in line with what they identify with? We may never know if the Olson-Kennedy study even considered psychiatric drug use prior to trans-treatments. It matters.
It’s no secret that psychiatric drugs can elicit strong adverse reactions, especially in children. For example, let’s consider Nashville school shooter Audrey Hale. Hale had been receiving psychiatric “treatment” for twenty of her twenty-eight years, and Hale had been prescribed cocktails of psychiatric drugs. So what role did the psychiatric drugs play in Hale’s desire to “transition”? Further, did Hale receive puberty-blockers and psychiatric drugs as a cocktail of “treatment?” It’s anyone’s guess at this point, as Hale’s extensive mental health records have not been made publicly available. Do we see a pattern of data-withholding among the trans-medical community?